Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shilpen A. Patel
Long Term Follow-Up of Neoadjuvant Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) Investigating Early Positron Emission Tomography (PET) Scan as a Predictor of Outcome
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
Positron Emission Tomography/Computed Tomography Imaging for Non-Small Cell Lung Cancer: A Budget Impact Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Imaging in Lung Cancer: Positron Emission Tomography Scan
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Positron Emission Tomography (PET) Radiotracers in Oncology – Utility of 18f-Fluoro-Deoxy-Glucose (FDG)-PET in the Management of Patients With Non-Small-Cell Lung Cancer (NSCLC)
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Promising Clinical Outcome With Long Term Follow-Up After Body Gamma Knife Stereotactic Radiosurgery for Patients With Early Stage Non-Small Cell Lung Cancer
Frontiers in Oncology
Cancer Research
Oncology
The Role of Positron Emission Tomography–Computed Tomography in the Workup of Non–Small Cell Lung Cancer
JAMA network open
Medicine
The Accuracy of Positron Emission Tomography in Mediastinal Staging of Non-Small Cell Lung Cancer
Turkish Journal of Thoracic and Cardiovascular Surgery
Respiratory Medicine
Pulmonary
Cardiovascular Medicine
Surgery
Cardiology
Value of Positron Emission Tomography/Computed Tomography (PET-CT) in Suspected Non-Small Cell Lung Cancer Recurrence and Impact on Patient Management
Acta Informatica Medica
Medicine
Positron Emission Tomography in T3/T4 Non-Small Cell Lung Cancer After Induction Chemoradiotherapy
Annals of Thoracic Surgery
Respiratory Medicine
Pulmonary
Cardiovascular Medicine
Surgery
Cardiology
Time Interval Between Staging FDG Positron Emission Tomography (PET) and Initiation of Stereotactic Lung Radiotherapy (SBRT) Impacts the Risk of Recurrence and Metastasis in Non-Small Cell Lung Cancer (NSCLC)
